In vitro PUVA treatment triggers calreticulin exposition and HMGB1 release by dying T lymphocytes in GVHD: New insights in extracorporeal photopheresis

Céline Coppard; Dalil Hannani; Marion Humbert; Virginie Gauthier; Joël Plumas; Etienne Merlin; Françoise Gabert; Laurence Chaperot

doi:10.1002/jca.21698

Journal articles

In vitro PUVA treatment triggers calreticulin exposition and HMGB1 release by dying T lymphocytes in GVHD: New insights in extracorporeal photopheresis

Céline Coppard Dalil Hannani ¹ Marion Humbert Virginie Gauthier Joël Plumas ² Etienne Merlin ³ Françoise Gabert ⁴ Laurence Chaperot ⁵

1 INSERM U823, équipe 9 (Immunobiologie et Immunothérapie des Cancers)

INSERM U823 - Institut d'oncologie/développement Albert Bonniot de Grenoble

2 Laboratoire recherche et développement

3 UNH - Unité de Nutrition Humaine

4 EFS Rhône-Alpes et Développement

5 IAB - Institute for Advanced Biosciences / Institut pour l'Avancée des Biosciences (Grenoble)

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Immunology

Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-02361628
Contributor : Laurence Chaperot <>
Submitted on : Friday, December 18, 2020 - 2:28:33 PM
Last modification on : Tuesday, February 23, 2021 - 3:26:12 PM

In vitro PUVA treatment triggers calreticulin exposition and HMGB1 release by dying T lymphocytes in GVHD: New insights in extracorporeal photopheresis

Files

Identifiers

Collections

Citation

Export

Metrics

242

72

In vitro PUVA treatment triggers calreticulin exposition and HMGB1 release by dying T lymphocytes in GVHD: New insights in extracorporeal photopheresis

Files

Identifiers

Collections

Citation

Export

Share

Metrics

242

72